PIONEER
Unknown
1,000 enrolled
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Phase 2 Unknown
31 enrolled
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Phase 1/2 Unknown
50 enrolled
Multi-site Validation and Application of a Consensus DSC-MRI Protocol
Phase NA Unknown
80 enrolled
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
Phase 1/2 Unknown
58 enrolled
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
Phase 1 Unknown
28 enrolled
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Phase 2 Unknown
58 enrolled
ALA
Phase 2 Unknown
18 enrolled
Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
Phase 2 Unknown
73 enrolled
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Phase 2 Unknown
80 enrolled
IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
Phase 1 Unknown
30 enrolled
Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Unknown
Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 1/2 Unknown
Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
Phase 3 Unknown
270 enrolled
Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Phase 2 Unknown
Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm
Phase 1/2 Unknown
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Phase 1 Unknown
24 enrolled
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
Phase 1 Unknown
12 enrolled
HBO
Phase 2 Unknown
20 enrolled
Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Phase 1 Unknown
60 enrolled
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
Phase 2 Unknown
66 enrolled